Get the Stockscreener App
118.65
1.46%
-1.76
Pre-market:
118.67
0.02
+0.02%
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $118.65, with a volume of 4.27M.
It is down -1.46% in the last 24 hours and down -1.53% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$120.41
Open:
$120.79
24h Volume:
4.27M
Relative Volume:
1.13
Market Cap:
$52.29B
Revenue:
$9.40B
Net Income/Loss:
$2.65B
P/E Ratio:
19.99
EPS:
5.935
Net Cash Flow:
$2.24B
1W Performance:
-7.43%
1M Performance:
-1.53%
6M Performance:
-29.63%
1Y Performance:
-32.11%
1-Day Range:
$118.47
$121.33
1-Week Range:
$118.47
$129.58
52-Week Range:
$115.25
$181.85
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
118.65 | 53.06B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.18 | 45.11B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.44B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.46 | 32.59B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
489.31 | 20.84B | 3.08B | 1.24B | 1.07B | 25.61 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Cerity Partners LLC Increases Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
California Public Employees Retirement System Cuts Stock Position in Zoetis Inc. $ZTS - MarketBeat
Animal Vaccines Market Top key Players 2035 | Vetoquinol, Heska - openPR.com
Edgestream Partners L.P. Has $1.73 Million Stake in Zoetis Inc. $ZTS - MarketBeat
Amundi Has $439.04 Million Stake in Zoetis Inc. $ZTS - MarketBeat
1832 Asset Management L.P. Acquires 9,472 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zoetis (ZTS) Gains Health Canada Approval for New Cat Osteoarthritis Treatment - GuruFocus
EBIT per share of Zoetis, Inc. Class A – GETTEX:ZOE - TradingView
Zoetis Says Health Canada Approves Long-Lasting Cat Osteoarthritis Drug - marketscreener.com
Zoetis receives Health Canada approval for feline arthritis therapy By Investing.com - Investing.com Australia
Zoetis receives Health Canada approval for feline arthritis therapy - Investing.com
Earnings are growing at Zoetis (NYSE:ZTS) but shareholders still don't like its prospects - Yahoo Finance
Zoetis receives Health Canada approval for Portela (Relfovetmab injection) - marketscreener.com
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats - Bakersfield.com
(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats - Business Wire
Invesco Ltd. Buys 468,173 Shares of Zoetis Inc. $ZTS - MarketBeat
Is Zoetis Inc. (ZOE) stock bottoming after sell offEarnings Recap Summary & Entry Point Confirmation Signals - Newser
Panagora Asset Management Inc. Sells 8,834 Shares of Zoetis Inc. $ZTS - MarketBeat
Why Zoetis Inc. (ZOE) stock stays on top picksJuly 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
Epoch Investment Partners Inc. Sells 187,530 Shares of Zoetis Inc. $ZTS - MarketBeat
Brown Advisory Inc. Purchases 250,829 Shares of Zoetis Inc. $ZTS - MarketBeat
Baird Financial Group Inc. Decreases Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Is Zoetis Inc. Class stock a momentum leaderPortfolio Return Report & Fast Gain Swing Trade Alerts - Newser
Zoetis Inc. (NYSE:ZTS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Is Zoetis Inc. (ZOE) stock a buy before earnings resultsOil Prices & Weekly Watchlist for Consistent Profits - Newser
Zoetis (ZTS) Up 1.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Transcript : Zoetis Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-04-2025 09 - marketscreener.com
Zoetis Inc. (ZTS): A bull case theory - MSN
Zoetis Inc. (ZTS): A Bull Case Theory - Insider Monkey
Zoetis Stock Plummets 24.8% YTD: Here's What You Need to Know - Nasdaq
BTIG Research Reiterates "Buy" Rating for Zoetis (NYSE:ZTS) - MarketBeat
Schroder Investment Management Group Decreases Holdings in Zoetis Inc. $ZTS - MarketBeat
Quantbot Technologies LP Sells 25,551 Shares of Zoetis Inc. $ZTS - MarketBeat
Why Zoetis Inc. Class stock is a strong analyst pick2025 Price Targets & AI Driven Stock Movement Reports - Newser
Zoetis Inc. $ZTS Shares Bought by Guggenheim Capital LLC - MarketBeat
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TD Cowen Adjusts Zoetis Price Target to $150 From $189, Maintains Buy Rating - marketscreener.com
Westerkirk Capital Inc. Invests $5.26 Million in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Position Reduced by M&T Bank Corp - MarketBeat
OMERS ADMINISTRATION Corp Buys 10,500 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Positioned for Long-Term Growth with Strategic Market Expansion and Innovative Product Launches - TipRanks
Rothschild & Co Redburn Adjusts Price Target on Zoetis to $165 From $195, Maintains Buy Rating - MarketScreener
Lido Advisors LLC Purchases 9,444 Shares of Zoetis Inc. $ZTS - MarketBeat
BTIG Reiterates Buy Rating for Zoetis (ZTS) with $160 Target Pri - GuruFocus
BTIG reiterates Buy rating on Zoetis stock after Innovation Day By Investing.com - Investing.com Nigeria
BTIG reiterates Buy rating on Zoetis stock after Innovation Day - Investing.com
Groupe la Francaise Acquires 21,534 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast - lelezard.com
Zoetis Inc. $ZTS Shares Purchased by Arrowstreet Capital Limited Partnership - MarketBeat
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.70%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):